Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
Completed · Phase 1
Conditions studied: HIV Infections
In brief
Tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) are two antiretroviral medications used for the treatment and prevention of HIV/AIDS. This study will examine how these medications are processed in the body of people who are HIV-infected, as well as in people who are HIV-uninfected.
Key facts
- Study ID
- NCT01040091
- Run by
- National Institute of Allergy and Infectious Diseases (NIAID)
- People needed
- 34
- Starts
- 2009-12-01
- Expected to finish
- 2014-04-01
- Last updated by the study team
- 2016-12-16
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Colorado CTRC CRS — Aurora, Colorado, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.